A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

But during tumour formation, the cancer cells can end up with only the faulty gene. "In cancer cells it is common that larger or smaller parts the chromosomes are lost. If the faulty gene variant is ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Patients with lung cancer who have never smoked are usually diagnosed too late for curative treatment. Pam Dalrymple, ...

Immunology is the study of the immune system and its defense mechanisms, and immuno-oncology is when cancer patients are ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...

The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...